When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARVN - Arvinas under pressure on early-stage ARV-110 data
Arvinas Inc.
Arvinas (NASDAQ:ARVN) is down 16% premarket on light volume after the release of an abstract on a Phase 1 clinical trial evaluating protein degrader ARV-110 in patients with metastatic treatment-resistant prostate cancer, the first in-human data on a drug with this mechanism of action in this population.
More news on: Arvinas, Inc., Healthcare stocks news, Stocks on the move,